Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | LPL | P06858 | 2/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 5/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.32 |
| ▸ | TTR | P02766 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14508350 | 1.00 | MGLL (0.37) | MGLLCA2CA1LPLLIPG | |
| SCHEMBL29633595 | 0.92 | CA2 (0.39) | CA2CA1LPLLIPGENPP2 | |
| SCHEMBL941721 | 0.92 | CA2 (0.39) | CA2CA1LPLLIPGENPP2 | |
| SCHEMBL14508336 | 0.92 | MGLL (0.52) | MGLLCA2CA1PDK2ENPP2 | |
| SCHEMBL13388829 | 0.92 | PDK2 (0.41) | MGLLCA2CA1PDK2 | |
| SCHEMBL18419417 | 0.92 | MGLL (0.52) | MGLLCA2CA1PDK2ENPP2 | |
| SCHEMBL14508331 | 0.92 | PDK2 (0.41) | MGLLCA2CA1PDK2 | |
| SCHEMBL14508339 | 0.92 | MGLL (0.52) | MGLLCA2CA1PDK2ENPP2 | |
| SCHEMBL30506456 | 0.92 | MGLL (0.52) | MGLLCA2CA1PDK2ENPP2 | |
| SCHEMBL12121799 | 0.89 | CA2 (0.37) | CA2CA1LPLLIPGENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158835-B2 | Fluorene compound and organic electroluminescence device | CANON KABUSHIKI KAISHA (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20090200919-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070122652-A1 | Compound and organic electroluminescent device using same | OR10J3, LEF1, RPL19 | MGLL 2273/4885CA2 3023/4885CA1 3092/4885 |
| US-20090200919-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | AFF1, LEF1, AFF2 | MGLL 2209/4885CA2 2875/4885CA1 2732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.